Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)

被引：0
作者：
Rezaie, Ali [1 ]
Heimanson, Zeev [2 ]
Israel, Robert J. [2 ]
McCallum, Richard [3 ]
Pimentel, Mark [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
468
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 50 条
[41]   Cilansetron in irritable bowel syndrome with diarrhea predominance (IBS-D) efficacy and safety in a 6 month global study [J].
Bradette, M ;
Moennikes, H ;
Carter, F ;
Krause, G ;
Caras, S ;
Steinborn, C .
GASTROENTEROLOGY, 2004, 126 (04) :A42-A42
[42]   Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea [J].
Lembo, Anthony ;
Rao, Satish S. C. ;
Heimanson, Zeev ;
Pimentel, Mark .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 :e00144
[43]   Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d) [J].
Breslin, Henry J. ;
Diamond, Craig J. ;
Kavash, Robert W. ;
Cai, Chaozhong ;
Dyatkin, Alexey B. ;
Miskowski, Tamara A. ;
Zhang, Sui-Po ;
Wade, Paul R. ;
Hornby, Pamela J. ;
He, Wei .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) :4869-4872
[44]   Cilansetron in irritable bowel syndrome with diarrhea predominance (IBS-D): Efficacy and safety in a 3 month US study [J].
Miner, P ;
Stanton, DB ;
Carter, F ;
Caras, S ;
Krause, G ;
Steinborn, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) :S277-S277
[45]   Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? [J].
Xu, Xiao-juan ;
Liu, Liang ;
Yao, Shu-kun .
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01) :1-9
[46]   Cilansetron improves health related quality of life in patients with irritable bowel syndrome with diarrhea predominance (IBS-D) [J].
Olden, KW ;
Drossman, DA ;
Carter, F ;
Caras, S ;
Krause, G ;
Steinborn, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) :S277-S277
[47]   Psychosocial determinants of rifaximin adherence for the treatment of diarrhea-predominant irritable bowel syndrome (IBS) [J].
Sherwin, L. ;
Krisanabud, P. ;
Deroche, C. ;
Matteson-Kome, M. ;
Ruppar, T. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
[48]   Lactulose hydrogen breath test in the diagnosis of irritable bowel syndrome (IBS) caused by food intolerance [J].
Sen, S ;
Dear, KLE ;
King, TS ;
Elia, M ;
Hunter, JO .
GUT, 2001, 48 :A57-A58
[49]   Characterizing Diarrhea in Irritable Bowel Syndrome (IBS) [J].
Palsson, Olafur S. ;
Turner, Marsha J. ;
Baggish, Jeffrey S. ;
Whitehead, William E. .
GASTROENTEROLOGY, 2009, 136 (05) :A376-A376
[50]   Lactulose Breath Test Gas Production and Clinical Correlation in Childhood Irritable Bowel Syndrome (IBS) [J].
Chumpitazi, Bruno P. ;
Weidler, Erica M. ;
Shulman, Robert .
GASTROENTEROLOGY, 2011, 140 (05) :S745-S745
12345